Merck to help produce rival J&J's COVID-19 vaccine
WASHINGTON (AP) — Drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly, a Biden administration official confirmed Tuesday.
The announcement comes as the White House looks to speed the production of the single-dose vaccine. Officials have said J&J faced unexpected production issues with its vaccine and produced only 3.9 million doses ahead of its receiving emergency use authorization on Saturday. The company says it is on pace to deliver 100 million doses by the end of June.
The assistance from Merck was expected to help J&J meet its production commitments and expand supply even further, but the administration did not immediately provide specifics.
President Joe Biden is set to highlight the development in a speech Tuesday afternoon. The official confirmed Merck’s involvement on condition of anonymity ahead of Biden’s public announcement.
The news was first reported by The Washington Post.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Harvey Adger, head basketball coach at Glen Oaks, notches 900th victory
Baton Rouge 10-year-old to compete in international Rubik's Cube competition
East Baton Rouge Parish schools work to find teachers amid nationwide teacher...
Jurors view graphic rape video in second day of Livingston sex abuse...
During call to 911 about prison fire, supervisors ask for police not...
WATCH: New LSU coach Brian Kelly arrives in Baton Rouge
High school coaches give Brian Kelly advice on how to tackle recruiting...
See the contract to get Brian Kelly as the new LSU Football...
Fans share their excitement about new LSU head coach Brian Kelly
New LSU coach Brian Kelly arrives in Baton Rouge